These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2941151)

  • 81. Epidermal growth factor-dependent phosphorylation of lipocortin.
    Pepinsky RB; Sinclair LK
    Nature; 1986 May 1-7; 321(6065):81-4. PubMed ID: 3010133
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Molecular modeling in the design of phospholipase A2 inhibitors.
    Ripka WC; Sipio WJ; Galbraith WG
    J Cell Biochem; 1989 Jul; 40(3):279-86. PubMed ID: 2777907
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Lipocortin I and lipocortin II inhibit phosphoinositide- and polyphosphoinositide-specific phospholipase C. The effect results from interaction with the substrates.
    Machoczek K; Fischer M; Söling HD
    FEBS Lett; 1989 Jul; 251(1-2):207-12. PubMed ID: 2546821
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Plipastatins: new inhibitors of phospholipase A2, produced by Bacillus cereus BMG302-fF67. I. Taxonomy, production, isolation and preliminary characterization.
    Umezawa H; Aoyagi T; Nishikiori T; Okuyama A; Yamagishi Y; Hamada M; Takeuchi T
    J Antibiot (Tokyo); 1986 Jun; 39(6):737-44. PubMed ID: 3089997
    [TBL] [Abstract][Full Text] [Related]  

  • 85. A discontinuous epitope on p36, the major substrate of src tyrosine-protein-kinase, brings the phosphorylation site into the neighbourhood of a consensus sequence for Ca2+/lipid-binding proteins.
    Johnsson N; Johnsson K; Weber K
    FEBS Lett; 1988 Aug; 236(1):201-4. PubMed ID: 2456953
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Alkylation of cysteine 82 of p11 abolishes the complex formation with the tyrosine-protein kinase substrate p36 (annexin 2, calpactin 1, lipocortin 2).
    Johnsson N; Weber K
    J Biol Chem; 1990 Aug; 265(24):14464-8. PubMed ID: 2143760
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Annexins and phospholipase A2 inhibition.
    Buhl WJ
    Eicosanoids; 1992; 5 Suppl():S26-8. PubMed ID: 1449824
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Biochemical and immunological properties of 34kDa EDTA-extractable protein (EEP34k)].
    Ohta A; Ohsaka K; Nakayama R; Kobayashi R; Sakuragi S
    Nippon Ganka Gakkai Zasshi; 1989 Jun; 93(6):636-45. PubMed ID: 2530857
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Inhibition of phospholipases by Met-Leu-Phe-Ile-Leu-Ile-Lys-Arg-Ser-Arg-His-Phe, C terminus of middle-sized tumor antigen.
    Notsu Y; Namiuchi S; Hattori T; Matsuda K; Hirata F
    Arch Biochem Biophys; 1985 Jan; 236(1):195-204. PubMed ID: 2857079
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Design and synthesis of conformationally restricted phospholipids as phospholipase A2 inhibitors.
    Magolda RL; Galbraith W
    J Cell Biochem; 1989 Jul; 40(3):371-86. PubMed ID: 2777909
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Isolation and characterization of lipocortin (lipomodulin).
    Hirata F; Notsu Y; Yamada R; Ishihara Y; Wano Y; Kunos I; Kunos G
    Agents Actions; 1986 Jan; 17(3-4):263-6. PubMed ID: 3962767
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Plipastatins: new inhibitors of phospholipase A2, produced by Bacillus cereus BMG302-fF67. III. Structural elucidation of plipastatins.
    Nishikiori T; Naganawa H; Muraoka Y; Aoyagi T; Umezawa H
    J Antibiot (Tokyo); 1986 Jun; 39(6):755-61. PubMed ID: 3089999
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Anti-phospholipase proteins.
    Di Rosa M; Flower RJ; Hirata F; Parente L; Russo-Marie F
    Prostaglandins; 1984 Oct; 28(4):441-2. PubMed ID: 6240666
    [No Abstract]   [Full Text] [Related]  

  • 94. Calpactins: calcium-regulated membrane-skeletal proteins.
    Glenney JR
    Biochem Soc Trans; 1987 Oct; 15(5):798-800. PubMed ID: 2961637
    [No Abstract]   [Full Text] [Related]  

  • 95. Syntheses of biologically active sialosylglycerol derivatives.
    Shimizu C; Achiwa K
    Chem Pharm Bull (Tokyo); 1989 Aug; 37(8):2258-60. PubMed ID: 2598333
    [TBL] [Abstract][Full Text] [Related]  

  • 96. A rapid assay for lipocortins using a continuous fluorescence displacement assay for phospholipase A2.
    Creaney A; Wilton DC
    Biochem Soc Trans; 1994 Aug; 22(3):306S. PubMed ID: 7821565
    [No Abstract]   [Full Text] [Related]  

  • 97. Modulation of tyrosine phosphorylation of p36 and other substrates by the S-100 protein.
    Hagiwara M; Ochiai M; Owada K; Tanaka T; Hidaka H
    J Biol Chem; 1988 May; 263(13):6438-41. PubMed ID: 2834378
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Human recombinant lipocortin 1 inhibits prostacyclin production by human umbilical artery in vitro.
    Cirino G; Flower RJ
    Prostaglandins; 1987 Jul; 34(1):59-62. PubMed ID: 2961007
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Tyrosine kinase substrate annexin II (p36)--biochemical characterization and conservation among species.
    Gerke V
    Biochem Soc Trans; 1990 Dec; 18(6):1106-8. PubMed ID: 2150941
    [No Abstract]   [Full Text] [Related]  

  • 100. Adherence and regulation of leukotaxis.
    Schiffmann E; Geetha V; Pencev D; Warabi H; Mato J; Hirata F; Brownstein M; Manjunath R; Mukherjee A; Liotta L; Terranova VP
    Agents Actions Suppl; 1983; 12():106-20. PubMed ID: 6573114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.